Joyn Bio

About Joyn Bio

Joyn Bio is a biotechnology startup that operates in the agricultural sector. It was initially established as a joint venture between Bayer and Ginkgo Bioworks in 2017. The company's primary focus is on the development and commercialization of nitrogen fixation technology, which aims to reduce the reliance on synthetic fertilizers in agriculture. This technology is designed to optimize the use of nitrogen, a key nutrient for plant growth, by enabling crops to absorb it directly from the air, thereby reducing the need for chemical fertilizers.

Recently, Joyn Bio's nitrogen fixation and R&D platform assets were fully integrated into Ginkgo Bioworks, as part of a deal with Bayer. This move is expected to accelerate the development of Joyn Bio's innovative nitrogen fixation platform. Bayer, in return, retains the right to commercialize the technology, indicating a potential revenue stream for Joyn Bio.

In addition to nitrogen fixation, Joyn Bio is also involved in the development of biological solutions for carbon sequestration and next-generation crop protection. These initiatives are part of a broader effort to provide sustainable, climate-smart, and innovative agricultural solutions. Bayer is the first major partner of Ginkgo Bioworks' expanded agricultural biologicals platform, which aims to bring high-quality biological solutions and innovative technologies to the market faster.

Joyn Bio's business model is based on partnerships with major agricultural companies like Bayer, who can commercialize their technology. This suggests a revenue model based on licensing or royalty fees from the commercialization of their technology.